Delivery Order SPE2DR25D2209-SPE2DR26FD7RR
Award Date 3/18/26
Potential Completion Date 3/19/26
Potential Value $5.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,433.34 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for atropine 1 mg/ml vial supply, with ultimate completion on March 5, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), an indefinite delivery contract valued at $999,999,999.00 and running through December 2026, which provides comprehensive pharmaceutical and medical supply support for military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a $11,246.01 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for atropine 1 mg/ml vial supply under a firm fixed-price structure. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 6, 2026. The delivery order was issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities...
- <p>The Defense Logistics Agency issued a $4,296.10 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for atropine 1 mg/ml vial supply, with ultimate completion on March 3, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for atropine 1 mg/mL vials with a ceiling value of $1,729.88. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This IDC provides pharmaceutical and medical supply support globally for military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm...
- The Defense Logistics Agency issued a $2,312.04 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for atropine 1 mg/10 ml syringes under a firm fixed-price arrangement. Place of performance is Conshohocken, PA. The ultimate completion date is March 5, 2026. This delivery order was issued under the company's parent indefinite delivery contract with DLA Troop Support Medical, a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and running through December...
- <p>The Defense Logistics Agency issued a $1,189.27 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for atropine 1 mg/10 ml syringes under its IDC with the DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 6, 2026. No set-aside was used.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Atropine 8 mg/20 ml vials. This firm fixed-price delivery order, valued at $1,458.66, is scheduled for completion by October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,134.87 to AmerisourceBergen Drug Corp for Atropine 1 mg/mL vials, with an ultimate completion date of August 27, 2025. This is a firm fixed-price, non-set-aside contract executed on August 26, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical supplier to the federal...
- The Defense Logistics Agency awarded a $1,654.50 delivery order to AmerisourceBergen Drug Corp for Atropine 8 mg/20 mL vials on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,266.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atropine 8 mg/20 ml vials. This non-set-aside contract, with an ultimate completion date of April 24, 2025, represents a single delivery order fulfillment under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD7RRDelivery Order
The Defense Logistics Agency issued a $5,128.14 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for atropine 1 mg/ml vial supply. The order is firm fixed price with an ultimate completion date of March 19, 2026. Place of performance is Conshohocken, PA. The order was issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999 through December 2026, which provides pharmaceutical and medical supply support for military healthcare programs worldwide.
Generated 6/17/26, 10:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 3/17/26 |